Literature DB >> 15555971

Adenocarcinoma of the gastric cardia: what is the optimal surgical approach?

Hiromichi Ito1, Thomas E Clancy, Robert T Osteen, Richard S Swanson, Raphael Bueno, David J Sugarbaker, Stanley W Ashley, Michael J Zinner, Edward E Whang.   

Abstract

BACKGROUND: The incidence of adenocarcinoma of the gastric cardia is rising in Western countries. This study evaluates prognostic factors associated with surgical management of this cancer. STUDY
DESIGN: Medical records of consecutive patients with gastric cardial cancer treated by surgical resection from 1991 through 2001 were reviewed. Survival was analyzed using the Kaplan-Meier method. Prognostic factors were evaluated using log-rank test and Cox regression. Mean followup period was 34 months.
RESULTS: Eighty-two patients met study inclusion criteria. Median patient age was 65 years (range 86 to 22). Fifty-nine (72%) patients had type II tumors and 23 (28%) patients had type III tumors, according to the Siewert classification for gastroesophageal junction tumors. Twenty-seven (33%) patients underwent total esophagectomy, 24 (29%) patients underwent extended gastrectomy with thoracotomy, and 31 (38%) patients underwent extended gastrectomy without thoracotomy. Overall postoperative 5-year survival rate was 30%. On multivariate analysis, patient age 65 years and older, absence of lymph node metastasis, and R0 resection emerged as factors independently associated with improved postoperative survival. Frequency with which proximal resection margin was infiltrated with cancer was a function of gross margin length and T stage. Proximal gross margin length of at least 6 cm was required to achieve a microscopically negative proximal margin for T3 and T4 cancers.
CONCLUSIONS: Achieving R0 resection should be the goal of surgical therapy for the gastric cardial cancer. The surgical approach should be tailored to individual patients to achieve this goal.

Entities:  

Mesh:

Year:  2004        PMID: 15555971     DOI: 10.1016/j.jamcollsurg.2004.08.015

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  39 in total

1.  Outcomes of Abdominal Total Gastrectomy for Type II and III Gastroesophageal Junction Tumors: Single Center's Experience in Korea.

Authors:  Kyoung Tai Kim; Oh Jeong; Mi Ran Jung; Seong Yeop Ryu; Young-Kyu Park
Journal:  J Gastric Cancer       Date:  2012-03-30       Impact factor: 3.720

Review 2.  Current role of surgical therapy in gastric cancer.

Authors:  Ryan Swan; Thomas J Miner
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

3.  Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.

Authors:  Chang-Ming Huang; Chen-Bin Lv; Jian-Xian Lin; Qi-Yue Chen; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu
Journal:  Surg Endosc       Date:  2016-12-15       Impact factor: 4.584

4.  Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer.

Authors:  Chang Min Lee; Ye Seob Jee; Ju-Hee Lee; Sang-Yong Son; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Protection of organs at risk during neoadjuvant chemoradiotherapy for gastric cancer based on a comparison between conformal and intensity-modulated radiation therapy.

Authors:  Leszek Hawrylewicz; Wojciech Leszczyński; Agnieszka Namysł-Kaletka; Iwona Bronclik; Jerzy Wydmański
Journal:  Oncol Lett       Date:  2016-05-26       Impact factor: 2.967

6.  Total esophagogastrectomy plus extended lymphadenectomy with transverse colon interposition: A treatment for extensive esophagogastric junction cancer.

Authors:  Marco Ceroni; Enrique Norero; Juan Pablo Henríquez; Eduardo Viñuela; Eduardo Briceño; Cristian Martínez; Gloria Aguayo; Fernando Araos; Paulina González; Alfonso Díaz; Mario Caracci
Journal:  World J Hepatol       Date:  2015-10-08

7.  Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study.

Authors:  Massimiliano Bissolati; Matteo Desio; Fausto Rosa; Stefano Rausei; Daniele Marrelli; Gian Luca Baiocchi; Giovanni De Manzoni; Damiano Chiari; Giovanni Guarneri; Fabio Pacelli; Lorenzo De Franco; Sarah Molfino; Chiara Cipollari; Elena Orsenigo
Journal:  Gastric Cancer       Date:  2016-01-05       Impact factor: 7.370

8.  Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.

Authors:  Norihiro Yuasa; Hideo Miyake; Tatsuharu Yamada; Tomoki Ebata; Yuji Nimura; Tatsuo Hattori
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

9.  Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.

Authors:  Andrew P Barbour; Nabil P Rizk; Mithat Gonen; Laura Tang; Manjit S Bains; Valerie W Rusch; Daniel G Coit; Murray F Brennan
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

10.  Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy.

Authors:  Ryan W Day; Brian D Badgwell; Keith F Fournier; Paul F Mansfield; Thomas A Aloia
Journal:  J Gastrointest Surg       Date:  2015-09-28       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.